Obesity and tumor growth: Inflammation, immunity, and the role of a ketogenic diet

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 19, Issue 4, 2016, Pages 294-299

  Wright, Christopher ^a   Simone, Nicole L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

immune dysregulation; inflammation; ketogenic diet; obesity

Indexed keywords

LEPTIN RECEPTOR; AUTACOID;

ADIPOSE TISSUE; ADJUVANT THERAPY; CALORIC RESTRICTION; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; DISEASE FREE SURVIVAL; HUMAN; IMMUNE DYSREGULATION; IMMUNOCOMPETENT CELL; INFLAMMATION; KETOGENIC DIET; LIPID DIET; LOW CARBOHYDRATE DIET; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; OBESITY; PHASE 3 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION; ADAPTIVE IMMUNITY; ANIMAL; ENDOCRINE DISEASE; EXERCISE; IMMUNOLOGY; IMMUNOPATHOLOGY; INNATE IMMUNITY; INTRA-ABDOMINAL FAT; LOW CALORY DIET; METABOLISM; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS); TUMOR VOLUME;

ADAPTIVE IMMUNITY; ADIPOSITY; ANIMALS; CARCINOGENESIS; COMBINED MODALITY THERAPY; DIET, KETOGENIC; DIET, REDUCING; ENDOCRINE SYSTEM DISEASES; EXERCISE; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; NEOPLASMS; OBESITY; TUMOR BURDEN;

EID: 84966714144     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000286     Document Type: Review

References (45)

1. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927; 8:519-530.
2. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United states, 2011-2014. NCHS Data Brief 2015; 219:1-8.
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-1638.
4. Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014; 384:755-765.
5. Ligibel JA, Alfano CM, Courneya KS, et al. American society of clinical oncology position statement on obesity and cancer. J Clin Oncol 2014; 32:3568-3574.
6. Goodwin PJ, Stambolic V. Impact of the obesity epidemic on cancer. Annu Rev Med 2015; 66:281-296.
7. Gilbert CA, Slingerland JM. Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med 2013; 64:45-57.
8. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity 2014; 41:36-48.
9. Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 2014; 26:54-74.
10. Cowen S, McLaughlin SL, Hobbs G, et al. High-fat, high-calorie diet enhances mammary carcinogenesis and local inflammation in MMTV-PyMT mouse model of breast cancer. Cancers (Basel) 2015; 7:1125-1142.
11. Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci 2015; 36:461-470.
12. Park JH, McMillan DC, Powell AG, et al. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer. Clin Cancer Res 2015; 21:882-888.
13. Bandaru P, Rajkumar H, Nappanveettil G. The impact of obesity on immune response to infection and vaccine: an insight into plausible mechanisms. Endocrinol Metab Synd 2013; 2:113.
14. Costanzo AE, Taylor KR, Dutt S, et al. Obesity impairs gammadelta T cell homeostasis and antiviral function in humans. PLoS One 2015; 10:e0120918.
15. Conde J, Scotece M, Abella V, et al. An update on leptin as immunomodulator. Expert Rev Clin Immunol 2014; 10:1165-1170.
16. Naylor C, Petri WA Jr. Leptin regulation of immune responses. Trends Mol Med 2016; 22:88-98.
17. Reis BS, Lee K, Fanok MH, et al. Leptin receptor signaling in T cells is required for Th17 differentiation. J Immunol 2015; 194:5253-5260.
18. Punt S, Langenhoff JM, Putter H, et al. The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review. Oncoimmunology 2015; 4:e984547.
19. Laue T, Wrann CD, Hoffmann-Castendiek B, et al. Altered NK cell function in obese healthy humans. BMC Obes 2015; 2:1.
20. Jahn J, Spielau M, Brandsch C, et al. Decreased NK cell functions in obesity can be reactivated by fat mass reduction. Obesity (Silver Spring) 2015; 23:2233-2241.
21. Young MR, Levingston C, Johnson SD. Cytokine and adipokine levels in patients with premalignant oral lesions or in patients with oral cancer who did or did not receive 1alpha, 25-dihydroxyvitamin D3 treatment upon cancer diagnosis. Cancers (Basel) 2015; 7:1109-1124.
22. Ligibel JA, Alfano CM, Hershman D, et al. Recommendations for obesity clinical trials in cancer survivors: American society of clinical oncology statement. J Clin Oncol 2015; 33:3961-3967.
23. Goodwin PJ, Segal RJ, Vallis M, et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol 2014; 32:2231-2239.
24. Harrigan M, Cartmel B, Loftfield E, et al. Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol 2016; 34:669-676.
25. Thomas Jefferson University Hospital. Caloric restriction in treating patients with stage 0-I breast cancer undergoing surgery and radiation therapy. In: Clinical-Trials.gov [Internet]. 2013. https://clinicaltrials.gov/ct2/show/NCT01819233. [NLM Identifier: NCT01819233] [Accessed 15 February 2016]
26. NCIC Clinical Trials Group. Health education materials with or without a physical activity program for patients who have undergone treatment for high-risk stage II or stage III colon cancer. In: ClinicalTrials.gov [Internet]. 2009. https://clinicaltrials.gov/ct2/show/NCT00819208. [NLM Identifier: NCT00819208] [Accessed 15 February 2016]
27. Gynecologic Oncology Group. Diet and physical activity change or usual care in improving progression-free survival in patients with previously treated stage II, III, or IV ovarian, fallopian tube, or primary peritoneal cancer. In: ClinicalTrials.gov [Internet]. 2008. https://clinicaltrials.gov/ct2/show/NCT00719303. [Identifier: NCT00719303] [Accessed 15 February 2016]
28. Alliance for Clinical Trials in Oncology. Diet in altering disease progression in patients with prostate cancer on active surveillance. In: ClinicalTrials.gov [Internet]. 2010. https://clinicaltrials.gov/ct2/show/NCT01238172. [Identifier: NCT01238172] [Accessed 15 February 2016]
29. University of Iowa. Ketogenic diet with concurrent chemoradiation for pancreatic cancer. In: ClinicalTrials.gov [Internet]. 2011. https://clinicaltrials.gov/ct2/show/NCT01419483. [Identifier: NCT01419483] [Accessed 15 February 2016]
30. University of Iowa. Ketogenic diet with chemoradiation for lung cancer (KETOLUNG). In: ClinicalTrials.gov [Internet]. 2011. https://clinicaltrials. gov/ct2/show/NCT01419587. [Identifier: NCT01419587] [Accessed 15 February 2016]
31. Universitätsmedizin Mannheim. Ketogenic or LOGI diet in a breast cancer rehabilitation intervention (KOLIBRI). In: ClinicalTrials.gov [Internet]. 2014. https://clinicaltrials.gov/ct2/show/NCT020927537. [Identifier: NCT020927 537] [Accessed 15 February 2016]
32. University of Iowa. Ketogenic diet phase 1 for head & neck cancer. In: ClinicalTrials.gov [Internet]. 2013. https://clinicaltrials.gov/ct2/show/NCT01975766. [Identifier: NCT01975766] [Accessed 15 February 2016]
33. Mid-Atlantic Epilepsy and Sleep Center, LLC. Ketogenic diet treatment ad-junctive to radiation and chemotherapy in glioblastoma multiforme: a pilot study. In: ClinicalTrials.gov [Internet]. 2014. https://clinicaltrials.gov/ct2/show/NCT02302235. [Identifier: NCT02302235] [Accessed 15 February 2016]
34. Michigan State University. Pilot study of a metabolic nutritional therapy for the management of primary brain tumors. In: ClinicalTrials.gov [Internet]. 2012. https://clinicaltrials.gov/ct2/show/NCT01535911. [Identifier: NCT01535911] [Accessed 15 February 2016]
35. Klement RJ, Ka mmerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab 2011; 8:75-175.
36. Gower BA, Goss AM. A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr 2015; 145:177S-183S.
37. Vidali S, Aminzadeh S, Lambert B, et al. Mitochondria: the ketogenic diet-a metabolism-based therapy. Int J Biochem Cell Biol 2015; 63:55-59.
38. Woolf EC, Scheck AC. The ketogenic diet for the treatment of malignant glioma. J Lipid Res 2015; 56:5-10.
39. Morscher RJ, Aminzadeh-Gohari S, Feichtinger RG, et al. Inhibition of neuro-blastoma tumor growth by ketogenic diet and/or calorie restriction in a CD1-nu mouse model. PLoS One 2015; 10:e0129802. doi: 10.1371/journal.-pone.0129802.
40. Martuscello RT, Vedam-Mai V, McCarthy DJ, et al. A supplemented high-fat low-carbohydrate diet for the treatment of glioblastoma. Clin Cancer Res 2015; doi: clincanres.0916.2015 [pii]
41. Seyfried TN, Flores R, Poff AM, et al. Metabolic therapy: a new paradigm for managing malignant brain cancer. Cancer Lett 2015; 356:289-300.
42. Woolf EC, Curley KL, Liu Q, et al. The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS One 2015; 10:e0130357.
43. Branca JJ, Pacini S, Ruggiero M. Effects of presurgical vitamin D supplementation and ketogenic diet in a patient with recurrent breast cancer. Anticancer Res 2015; 35:5525-5532.
44. Hao GW, Chen YS, He DM, et al. Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3 fatty acids and medium-chain triglycerides. Asian Pac J Cancer Prev 2015; 16:2061-2068.
45. Meidenbauer JJ, Mukherjee P, Seyfried TN. The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer. Nutr Metab (Lond) 2015; 12:12.